CClinicalTrials.gg
CompletedNCT05968300Updated Nov 22, 2024

Getting INFORMED and Living Well Among Asian Americans in California

An interventional study of INFORMED-Living Well and Text Messaging Only in COVID-19 and Well-Being, Psychological, sponsored by University of California, San Francisco. Completed at 4 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-11-22.

Sponsored by University of California, San Francisco · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
616
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The project is to facilitate pandemic recovery by promoting emotional wellness among Asian Californians. The intervention includes a 6-week program in which participants may choose to receive text only or text + Lay Health Worker outreach targeting 600 self-identified Asian Americans residing in California who speak/read English, Chinese, Korean, Hmong, or Vietnamese.

Read the detailed description

Investigators will conduct a non-randomized intervention trial (preference trial). Research participants involved in the trial will include 20 lay health workers (LHWs) and 600 trial participants with intervention delivered via SMS text messaging (for all participants), and the intervention group will receive educational intervention outreach from an LHW via Zoom or mutually agreed video conferencing online venues, and by telephone or instant messaging. Participants will choose which group they are in, SMS text messaging only or SMS text messaging plus educational outreach from an LHW.

02

Conditions studied

  • COVID-19
  • Well-Being, Psychological

Keywords

  • Asian Americans
  • Peer Education
  • Immigrants
  • Chinese
  • Hmong
  • Korean
  • Vietnamese
03

In context

Lead sponsor

University of California, San Francisco is the lead sponsor of 2,132 studies on the registry; 375 are open to participants now.

Of its 262 completed or terminated interventional studies of FDA-regulated products, 196 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

i) age 18 and older

ii) speak Chinese, English, Hmong, Korean, or Vietnamese

iii) self-identify as Asian American

iv) have access to a mobile phone to receive SMS text messages

Exclusion criteria

Exclusion Criteria:

  • unwilling to receive SMS text messages from the project
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
616 participants (actual)

Study arms

  • Experimental
    INFORMED-Living Well

    INFORMED-Living Well consists of two components: 1) LHW outreach support providing responsive education and support; and 2) a 6-week automated SMS text messaging. The LHW educational outreach component includes 2 small group educational sessions with 2-8 participants. Participants will also receive a weekly SMS Text or instant message on managing emotional wellness within and beyond the context of the COVID-19 pandemic over 6 weeks. In addition, participants will receive as-needed messages on updates of COVID-19 or other situations that may introduce new worries and tragic culturally-based traumatic events.

    Behavioral: INFORMED-Living Well

  • Active comparator
    Text Messaging Only

    Participants will have a 6-week SMS text messaging program identical to that received by the INFORMED-Living Well participants.

    Behavioral: Text Messaging Only

Interventions

  • BehavioralINFORMED-Living Well

    1) LHW outreach support providing responsive education and support; and 2) a 6-week automated SMS text messaging

  • BehavioralText Messaging Only

    A 6-week automated SMS text messaging

06

What researchers measure

Primary outcomes

  1. Change in decisional conflict scale (SURE) scores

    Self-assessed perceptions of decision conflict will be assessed using the 4-item Decision Conflict Scale (SURE). Scores on the SURE scale range from 0 to 4, with higher scores indicating less decisional conflict. A score of less than 4 indicates decisional conflict.

    Time frame: Baseline and 8-week follow-up

Secondary outcomes

  1. Change in proportion of participants who have Intention to seek help for mental health

    We will use a survey item to assess participants' intention to seek help for mental health issues when needed. A response will be 0 (No) or 1 (Yes).

    Time frame: Baseline and 8-week follow-up

  2. Change in self-reported emotional wellness outcome

    We will use the four-item Patient Health Questionnaire (PHQ4) for measuring anxiety and depression symptoms. Scores are rated as normal (0-2), mild (3-5), moderate (6-8), and severe (9-12). Total score 3 or higher for the first 2 questions suggests anxiety, and total score 3 or higher for the last 2 questions suggests depression.

    Time frame: Baseline and 8-week follow-up

  3. Change in the percentage of participants' awareness of resources to get help or to learn more about improving emotional wellness

    We will assess participants' awareness of resources to get help or to learn more about improving emotional wellness. Two items created for the study will be used: 1) Do you know about "988"? (Yes, No, Unsure) 2) Do you know where to get help for mental health issues when you need to? (Yes, No, Unsure). The percentage of participants who answer "yes" to both questions will be assessed.

    Time frame: Baseline and 8-week follow-up

07

Study locations

4 sites
  • The Fresno Center
    Fresno, California 93727, United States
  • Chinese Community Health Resource Center
    San Francisco, California 94133, United States
  • University of California, San Francisco
    San Francisco, California 94143, United States
  • Immigrant Resettlement & Cultural Center
    San Jose, California 95131, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 22, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05968300
Lead sponsor
University of California, San Francisco
Collaborators
Chinese Community Health Resource Center, University of California, Davis, University of California, Merced, California Department of Public Health
Responsible party
Sponsor
First posted
Aug 1, 2023
Start date
Mar 20, 2024
Primary completion
Aug 31, 2024
Completion
Aug 31, 2024
Last update
Nov 22, 2024

Study contacts

Janice Tsoh, PhD
principal investigator · University of California, San Francisco

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion